Atriance nelarabine regulatory update

CHMP issued a positive opinion to grant marketing approval to an MAA for Atriance nelarabine from GSK to treat T cell acute lymphoblastic leukemia (ALL) and T cell lymphoblastic lymphoma (LBL) in pati...